Press
EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology
Posted on December 1, 2009 by Admin EpivaxView Press Release as PDF DECEMBER 1, 2009, Providence, RI EpiVax, Inc. today announced a collaborative research agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY) aimed at evaluating EpiVax’s proprietary Tregitope technology, which could potentially reduce detrimental immune responses to certain drugs. In the course of the Roche-EpiVax collaboration, the EpiVax Tregitope technology will be evaluated for ...Read moreProvidence’s Jewelry District: Growth hotspot?
Posted on November 16, 2009 by Admin EpivaxRead the article at projo.com Providence’s Jewelry District: Growth hotspot? 01:00 AM EST on Saturday, November 14, 2009 By Philip Marcelo Journal Staff Writer PROVIDENCE — U.S. Rep. David R. Obey, chairman of the House Appropriations Committee, toured four major research institutions in the city’s Jewelry District on Friday along with Rep. Patrick J. Kennedy, ...Read morePolly Matzinger Fearless Scientist Award
Posted on November 13, 2009 by Admin EpivaxRead article at URI website URI biotech student awarded Fearless Scientist Scholarship by Institute for Immunology & Informatics Media Contact: Todd McLeish, 401-874-2116 PROVIDENCE, R.I. – November 4, 2009 – During a nearly 30-year career, Cranston resident Kathy Vachon has operated a foot press, sold insurance, worked as a diet aide at a nursing home, been a ...Read moreBoston Herald Business News: Annie De Groot Proves the Power of One Person
Posted on October 7, 2009 by Admin EpivaxBy Helen Graves Read article at BostonHerald.com It’s a wonder, but yet no surprise, that Annie De Groot, EpiVax founder, CEO and CSO, is pioneering new fields in infectious and autoimmune diseases while also paying attention to the least served – and doing so in so many ways. “What explains my life is: Stop talking and start acting,” ...Read moreOpen Registration for Spring 2010 URI Class
Posted on September 6, 2009 by Admin EpivaxMTC 594 – Special Problems in Biotechnology Topic: Development of Vaccines and Immunotherapeutics Instructor: Dr. Anne S. De Groot, M.D. Days & Times: Wed. 5:00 p.m. -7:45 p.m. Meeting Dates: 1/25/2010 – 5/3/2010 Location: University of Rhode Island, Providence Campus (Shepard Building, Room 302) Address: 80 Washington Street, Providence RI Prerequisites: graduate standing and permission of chairperson. For more information: URI Course Catalog URI E-Campus Course ...Read moreEpiVax, De Groot focus of WRNI feature on biotech and the “knowledge economy”
Posted on August 24, 2009 by Admin Epivaxbiotech and the “knowledge economy” Can Higher Ed Boost Biotech Start-Ups In RI? Providence officials are expected to unveil details of a plan next month to turn part of downtown into a hub for biotechnology and small start-up companies. WRNI education reporter Elisabeth Harrison looks at a shift at colleges and universities that may help strengthen the ...Read moreEpiVax, De Groot focus of WRNI feature on biotech and the "knowledge economy"
Posted on August 24, 2009 by Annie De Grootbiotech and the “knowledge economy” Can Higher Ed Boost Biotech Start-Ups In RI? Providence officials are expected to unveil details of a plan next month to turn part of downtown into a hub for biotechnology and small start-up companies. WRNI education reporter Elisabeth Harrison looks at a shift at colleges and universities that may help strengthen the ...Read moreCicilline cites EpiVax as socially-conscious company
Posted on August 19, 2009 by Admin EpivaxThe Bottom Line: Rebranding a City 19 August 2009 David N Cicilline, Mayor of Providence, Rhode Island in the US ‘Providence is fast becoming a hot-bed for young social entrepreneurs, those creative individuals who take an innovative, untested idea for positive social change and develop it using entrepreneurial principles’ How one city is using social enterprise to turn around ...Read moreMass High Tech Business News: De Groot wins $13M NIH Grant
Posted on July 31, 2009 by Admin EpivaxRead the original MHT article By Brendan Lynch The University of Rhode Island reports researcher Annie DeGroot has landed a $13 million grant from the National Institutes of Health to develop a multidisciplinary program to develop vaccines for infectious diseases. The research is being led by DeGroot, the director of the school’s Institute for Immunology and Informatics, and ...Read moreProvidence Business News: De Groot wins $13M NIH grant
Posted on July 29, 2009 by Admin EpivaxRead the original Providence Business News article By PBN Staff PROVIDENCE – Prominent local researcher and University of Rhode Island professor Dr. Anne S. De Groot has been awarded a $13 million research grant from the National Institutes of Health. It is the second large NIH grant awarded to URI researchers in recent months. In May, a pharmacy ...Read moreProvidence Journal: URI wins $13-million federal grant for vaccine research
Posted on July 29, 2009 by Admin EpivaxRead the original article in the Providence Journal By C. Eugene Emery Jr. PROVIDENCE — Dr. Annie De Groot and her colleagues think they have a better way of speeding the development of vaccines against Lyme disease, hepatitis and stomach cancer. The federal government apparently believes their ideas are worth a ...Read moreURI researcher awarded $13 million grant for development of vaccines for emerging infectious diseases
Posted on July 29, 2009 by Admin EpivaxSimulation tools used to train next generation of scientific researchers PROVIDENCE, R.I. – July 28, 2009 University of Rhode Island Professor Annie De Groot has been awarded a $13 million grant from the National Institutes of Health to pioneer the development and application of an integrated gene-to-vaccine program targeting emerging infectious diseases. It is the second multi-million ...Read moreEpiVax Research to be Presented at Numerous Conferences this Autumn
Posted on July 29, 2009 by Admin EpivaxEpiVax is proud to be presenting our research findings at numerous conferences in the coming months, including: Strategies for Engineered Negligible Senescence (SENS4) 3rd Annual Therapeutic Monoclonal Antibody Discovery Immunogenicity Testing: Clinical and Regulatory Strategy for Biopharmaceuticals Immunogenicity Summit Three oral and two poster presentations at 2nd European Congress of ImmunologyRead moreProvidence Business News profiles Dr. Anne De Groot
Posted on June 2, 2009 by Admin EpivaxVaccine research has helped her make a difference By Marion Davis Contributing Writer SEARCHING FOR A CURE: Anne De Groot founded EpiVax in 1998 with her research partner Bill Martin. The company has developed vaccines for HIV, tuberculosis, smallpox and other diseases. PBN PHOTO/STEPHANIE EWENS Dr. Anne S. De Groot went to medical school, she said, “to right the wrongs ...Read moreDr. De Groot honored at PBN Business Women Awards luncheon
Posted on May 21, 2009 by Admin EpivaxPBN honors Business Women winners By PBN Staff PROVIDENCE – Providence Business News today held a luncheon to recognize the accomplishments of the 26 women honored over the past year as part of the newspaper’s second annual program recognizing women in the Rhode Island business community. The luncheon this afternoon at the Providence Marriott Downtown on Orms Street ...Read more
Join our newsletter
We strive to provide our clients, collaborators and everyday immunology enthusiasts with valuable content. Written by our CEO/CSO Dr. Anne Dr Groot, you can expect up to date vaccine development efforts, upcoming events and so much more from our offices here in Providence, RI.